METHODS: Patients with newly diagnosed high-grade gliomas received BCNU and cisplatin after surgery, both before and during definitive radiation therapy.
Early results have shown promise for extending survival in patients with highly aggressive brain tumors called gliomas.
The study focused on patients with high-grade relapsed gliomas.
Early studies using this drug have shown some promise for treating people with high-grade gliomas.
It is used in some specialist centers to treat high grade gliomas that have come back, or started to grow again.